162 related articles for article (PubMed ID: 30826059)
1. TAT peptide-modified cisplatin-loaded iron oxide nanoparticles for reversing cisplatin-resistant nasopharyngeal carcinoma.
Weng H; Bejjanki NK; Zhang J; Miao X; Zhong Y; Li H; Xie H; Wang S; Li Q; Xie M
Biochem Biophys Res Commun; 2019 Apr; 511(3):597-603. PubMed ID: 30826059
[TBL] [Abstract][Full Text] [Related]
2. GSH triggered intracellular aggregated-cisplatin-loaded iron oxide nanoparticles for overcoming cisplatin resistance in nasopharyngeal carcinoma.
Bejjanki NK; Xu H; Xie M
J Biomater Appl; 2021 Jul; 36(1):45-54. PubMed ID: 33402041
[TBL] [Abstract][Full Text] [Related]
3. [Synthesis of cell penetrating peptide decorated magnetic nanoparticles loading cisplatin for nasopharyngeal cancer therapy].
Quan LM; Zhong Y; Weng HH
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jul; 32(13):963-968. PubMed ID: 29986554
[No Abstract] [Full Text] [Related]
4. Preparation of FA-targeted magnetic nanocomposites co-loading TFPI-2 plasmid and cis-platinum and its targeted therapy effects on nasopharyngeal carcinoma.
Liu F; Chen B; Chen W; Chen S; Ma D; Xie M
Int J Med Sci; 2021; 18(11):2355-2365. PubMed ID: 33967612
[TBL] [Abstract][Full Text] [Related]
5. O(6) -methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma.
Chen SH; Kuo CC; Li CF; Cheung CH; Tsou TC; Chiang HC; Yang YN; Chang SL; Lin LC; Pan HY; Chang KY; Chang JY
Int J Cancer; 2015 Sep; 137(6):1291-305. PubMed ID: 25693518
[TBL] [Abstract][Full Text] [Related]
6. [Preparation of folate-targeted magnetic nanocomposites loaded with TFPI-2 plasmid and cisplatin and evaluation of its targeting and inhibitory effect on nasopharyngeal carcinoma HNE-1 cells in vitro].
Liu RZ; Zhang J; Liu T; Fu XY; Zhang LM; Xie MQ
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(25):2023-30. PubMed ID: 27470963
[TBL] [Abstract][Full Text] [Related]
7. Expression of folate receptors in nasopharyngeal and laryngeal carcinoma and folate receptor-mediated endocytosis by molecular targeted nanomedicine.
Xie M; Zhang H; Xu Y; Liu T; Chen S; Wang J; Zhang T
Int J Nanomedicine; 2013; 8():2443-51. PubMed ID: 23874095
[TBL] [Abstract][Full Text] [Related]
8. [miR-129-1-3p reverses cisplatin resistance of HNE1/CDDP human nasopharyngeal carcinoma cells by targeting inhibition of WEE1 kinase].
Zhang H; Lu J; Jiang C; Lu W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):1014-1019. PubMed ID: 31878998
[TBL] [Abstract][Full Text] [Related]
9. Reversal of cisplatin sensitization and abrogation of cisplatin-enriched cancer stem cells in 5-8F nasopharyngeal carcinoma cell line through a suppression of Wnt/β-catenin-signaling pathway.
Sinnung S; Janvilisri T; Kiatwuthinon P
Mol Cell Biochem; 2021 Apr; 476(4):1663-1672. PubMed ID: 33423190
[TBL] [Abstract][Full Text] [Related]
10. [Effect of targeted therapy with cisplatin-loaded magnetic nanoparticles combined with radiotherapy for nasopharyngeal carcinoma in nude mice].
Long Z; Xie MQ; Zhang T; Shen H; Xu XQ; Guo L
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Sep; 29(9):1827-30. PubMed ID: 19778802
[TBL] [Abstract][Full Text] [Related]
11. Pheophorbide co-encapsulated with Cisplatin in folate-decorated PLGA nanoparticles to treat nasopharyngeal carcinoma: Combination of chemotherapy and photodynamic therapy.
Zhou B; Ma Y; Li L; Shi X; Chen Z; Wu F; Liu Y; Zhang Z; Wang S
Colloids Surf B Biointerfaces; 2021 Dec; 208():112100. PubMed ID: 34547704
[TBL] [Abstract][Full Text] [Related]
12. Identification Keratin 1 as a cDDP-resistant protein in nasopharyngeal carcinoma cell lines.
Tang S; Huang W; Zhong M; Yin L; Jiang H; Hou S; Gan P; Yuan Y
J Proteomics; 2012 Apr; 75(8):2352-60. PubMed ID: 22348822
[TBL] [Abstract][Full Text] [Related]
13. Comparative Proteomic Profiling of Cisplatin-resistant Nasopharyngeal Carcinoma Cell Lines: Novel Biomarkers for Improving Chemotherapy of NPC.
Prathaphan P; Reamtong O; Ngaokrajang U; Janvilisri T; Swainson NM; Kiatwuthinon P
Anticancer Res; 2022 Jul; 42(7):3507-3522. PubMed ID: 35790268
[TBL] [Abstract][Full Text] [Related]
14. MTA1 overexpression induces cisplatin resistance in nasopharyngeal carcinoma by promoting cancer stem cells properties.
Feng X; Zhang Q; Xia S; Xia B; Zhang Y; Deng X; Su W; Huang J
Mol Cells; 2014 Sep; 37(9):699-704. PubMed ID: 25245523
[TBL] [Abstract][Full Text] [Related]
15. [Combination of cytosine arabinoside and cisplatin enhances inhibition of cell proliferation and promotes apoptosis of resistant nasopharyngeal carcinoma cells].
Chen J; Liu S; Li Q; Peng J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):379-82, 386. PubMed ID: 25744845
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, Molecular Docking, and Tumor Resistance Reversal Activity Evaluation of Matrine Derivative with Thiophene Structure.
Wei J; Liang Y; Wu L
Molecules; 2021 Jan; 26(2):. PubMed ID: 33466857
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of GRP78 enhances cell death by cisplatin and radiotherapy in nasopharyngeal cells.
Huang YY; Pu LJ; Song LL; Ma LY; Liu H; Jiang CC
Anticancer Drugs; 2016 Sep; 27(8):726-33. PubMed ID: 27254284
[TBL] [Abstract][Full Text] [Related]
18. 3'-ethynylcytidine, an RNA polymerase inhibitor, combined with cisplatin exhibits a potent synergistic growth-inhibitory effect via Vaults dysfunction.
Fukushima H; Abe T; Sakamoto K; Tsujimoto H; Mizuarai S; Oie S
BMC Cancer; 2014 Aug; 14():562. PubMed ID: 25087851
[TBL] [Abstract][Full Text] [Related]
19. FBW7 increases drug sensitivity to cisplatin in human nasopharyngeal carcinoma by downregulating the expression of multidrug resistance-associated protein.
Song Y; Zhou X; Bai W; Ma X
Tumour Biol; 2015 Jun; 36(6):4197-202. PubMed ID: 25586348
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells.
Liu Z; Liu J; Li L; Nie D; Tao Q; Wu J; Fan J; Lin C; Zhao S; Ju D
PLoS One; 2015; 10(8):e0135236. PubMed ID: 26288183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
